Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 6/20 | 0.44 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.44 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | CDC25A | P30304 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL102703 | 1.00 | PLA2G2A (0.44) | PLA2G2APLA2G10PLA2G1BPLA2G5LPAR1 | |
| SCHEMBL14767811 | 0.92 | PLA2G2A (0.41) | PLA2G2APLA2G10PLA2G1BPLA2G5LPAR1 | |
| SCHEMBL7584842 | 0.84 | MAPK1 (0.60) | KMT2AMAPK1 | |
| SCHEMBL14803813 | 0.81 | CHRM2 (0.55) | KMT2A | |
| SCHEMBL14803815 | 0.81 | CHRM2 (0.55) | KMT2A | |
| SCHEMBL15267482 | 0.81 | MAOB (0.48) | — | |
| SCHEMBL14803822 | 0.81 | CHRM2 (0.55) | KMT2A | |
| SCHEMBL14803817 | 0.81 | CHRM2 (0.55) | KMT2A | |
| SCHEMBL10198316 | 0.80 | ALDH1A1 (0.42) | KMT2A | |
| SCHEMBL10107970 | 0.80 | ALDH1A1 (0.42) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002072068-A2 | LIPIDS, LIPID COMPOSITIONS, LIPOSOMES, AND LIPOPLEXES | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2002-09-19 | — | — | WO | disclosed |